Image

Patient Reported Experiences and Outcomes Associated with Standard C-Section Wound Closure Versus STRATAFIX/DERMABOND PRINEO Wound Closure (CS-PREO)

Patient Reported Experiences and Outcomes Associated with Standard C-Section Wound Closure Versus STRATAFIX/DERMABOND PRINEO Wound Closure (CS-PREO)

Recruiting
18 years and older
Female
Phase N/A

Powered by AI

Overview

The aim of the study is to compare outcomes between patients receiving standard C-section wound closure compared to a wound closure bundle that includes Stratafix sutures and Dermabond PRINEO.

Description

The purpose of this study is to evaluate patient experience and patient reported outcomes following cesarean delivery in women receiving either standard wound closure or a wound closure bundle which includes both Stratfix sutures and Dermabond Prineo.

Patients in both study arms will complete established questionnaires capturing patient-reported experience measures (PREMS) and patient-reported outcome measures (PROMS).

Eligibility

Inclusion Criteria:

  1. Patient must be 18 years of age or older at time of recruitment
  2. Patients opting for a planned (elective) C-Section (13-36 weeks gestation) will be eligible to consent.
  3. Patients must have internet access and/or a smartphone in order to access the digital platform to complete the study questionnaires
  4. Patients must speak and write in English as study questionnaires will only be provided in English
  5. Patients must have coverage from the Ontario Health Insurance Plan (OHIP)

Exclusion Criteria:

  1. Patients assessed by the participating surgeon with any conditions that may compromise their:
    • Ability to consent or use the virtual care platform (e.g., patients with intellectual disabilities)
    • Expectation of significant maternal complications that may affect the surgery
  2. Patients who enroll in the study but have an unplanned emergency C-section

Study details
    Cesarean Section; Complications
    Wound
    Infection (Following Delivery)

NCT06614829

North York General Hospital

15 October 2025

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.